View in EDS

Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: a phase-II study (no. 06901) of the EORTC Leukemia Cooperative Group.

Saved in:
Bibliographic Details
Title: Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: a phase-II study (no. 06901) of the EORTC Leukemia Cooperative Group.
Authors: De Witte T; Department of Internal Medicine, University Hospital St. Radboud, Nijmegen, The Netherlands., Suciu S, Selleslag D, Labar B, Roozendaal K, Zittoun R, Ribeiro M, Kurstjens R, Hayat M, Dardenne M, Solbu G, Muus P
Source: Annals of hematology [Ann Hematol] 1996 Mar; Vol. 72 (3), pp. 119-24.
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print Cited Medium: Print ISSN: 0939-5555 (Print) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 8766252
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: a phase-II study (no. 06901) of the EORTC Leukemia Cooperative Group.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22De+Witte+T%22">De Witte T</searchLink>; Department of Internal Medicine, University Hospital St. Radboud, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Suciu+S%22">Suciu S</searchLink><br /><searchLink fieldCode="AU" term="%22Selleslag+D%22">Selleslag D</searchLink><br /><searchLink fieldCode="AU" term="%22Labar+B%22">Labar B</searchLink><br /><searchLink fieldCode="AU" term="%22Roozendaal+K%22">Roozendaal K</searchLink><br /><searchLink fieldCode="AU" term="%22Zittoun+R%22">Zittoun R</searchLink><br /><searchLink fieldCode="AU" term="%22Ribeiro+M%22">Ribeiro M</searchLink><br /><searchLink fieldCode="AU" term="%22Kurstjens+R%22">Kurstjens R</searchLink><br /><searchLink fieldCode="AU" term="%22Hayat+M%22">Hayat M</searchLink><br /><searchLink fieldCode="AU" term="%22Dardenne+M%22">Dardenne M</searchLink><br /><searchLink fieldCode="AU" term="%22Solbu+G%22">Solbu G</searchLink><br /><searchLink fieldCode="AU" term="%22Muus+P%22">Muus P</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 1996 Mar; Vol. 72 (3), pp. 119-24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0939-5555 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=8766252
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s002770050148
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 119
    Titles:
      – TitleFull: Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: a phase-II study (no. 06901) of the EORTC Leukemia Cooperative Group.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: De Witte T
      – PersonEntity:
          Name:
            NameFull: Suciu S
      – PersonEntity:
          Name:
            NameFull: Selleslag D
      – PersonEntity:
          Name:
            NameFull: Labar B
      – PersonEntity:
          Name:
            NameFull: Roozendaal K
      – PersonEntity:
          Name:
            NameFull: Zittoun R
      – PersonEntity:
          Name:
            NameFull: Ribeiro M
      – PersonEntity:
          Name:
            NameFull: Kurstjens R
      – PersonEntity:
          Name:
            NameFull: Hayat M
      – PersonEntity:
          Name:
            NameFull: Dardenne M
      – PersonEntity:
          Name:
            NameFull: Solbu G
      – PersonEntity:
          Name:
            NameFull: Muus P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 1996 Mar
              Type: published
              Y: 1996
          Identifiers:
            – Type: issn-print
              Value: 0939-5555
          Numbering:
            – Type: volume
              Value: 72
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Annals of hematology
              Type: main
ResultId 1